Preview

Problems of Endocrinology

Advanced search

The prevalence of diabetes mellitus among the patients with acromegaly

https://doi.org/10.14341/probl20125839-11

Abstract

To estimate the prevalence of diabetes mellitus (DM) among the patients with acromegaly residing in the Moscow region (MR). A total of 93 patients aged from 48.0 to 64.5 (mean 57.5) years presenting with acromegaly from 7.5 to 20.25 (mean 13.0) years in duration were available for the examination. Twenty seven of these patients developed diabetes mellitus prior to acromegaly. Oral glucose tolerance test (OGTT) for diagnostics of DM was performed in 66 patients. The overall prevalence of diabetes mellitus among the patients with acromegaly was estimated at 51.6% which is higher than that in the general population of the Moscow region and worldwide (2.3% and 8.3% respectively). The prevalence of DM among women was higher than in men (55.1% and 33.5% respectively; p<0.05). It increased with age (from 14.3% in the patients aged between 36 and 45 years to 48.3% at the age above 56 years) and with duration of acromegaly (from 40.6% in the patients with the duration of the disease up to 8 years to 60.5% in those with acromegaly during more than 15 years; p<0.05). Asymptomatic diabetes was diagnosed in 34.8% of the 69 patients which is also higher than the prevalence of asymptomatic type 2 diabetes mellitus in a random sample from the adult population of MR and in the group with the enhanced risk of DM2. The prevalence of DM among the patients in the controllable and uncontrolled phases of acromegaly was 57.1% and 49.2% respectively (p>0.05). The prevalence of DM2 among the patients with acromegaly is significantly higher than in the world's general population; it depends on the patients' age and sex and as well as on the duration of acromegaly.

References

1. Holdaway I.M., Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999; 1: 29-41.

2. Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrinol Rev 2004; 25: 102-152.

3. Nabarro J.D.N. Acromegaly. Clin Endocrinol (Oxford) 1987; 26: 481-512.

4. Kreze A., Kreze-Spirova E., Mikulecky M. Risk factors for glucose intolerance in active acromegaly. Braz J Med Biol Res 2001; 34: 1429-1433.

5. Colao A., Pivonello R., Galderisi M., Cappabianca P., Auriemma R.S., Galdiero M., Cavallo L.M., Esposito F., Lombardi G. Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. J Clin Endocrinol Metabol 2008; 93: 2639-2646.

6. IDF Diabetes Atlas.5-th Ed. Int Diabet Federation 2011; 7.

7. Melmed S., Colao A., Barkan A., Molitch M., Grossman A. B., Kleinberg D., Clemmons D., Chanson P., Laws E., Schlechte J., Vance M.L., Ho K., Giustina A. Guidelines for Acromegaly Management: an Update. J Clin Endocrinol Metab 2009; 94: 5: 1509-1517.

8. Definition, diagnosis and classification of Diabetes Mellitus and its complications. WHO (Geneva) 1999.

9. Ковалева Ю.А. Основные эпидемиологические параметры и анализ медикаментозной терапии сахарного диабета 2-го типа: Автореф. дис. ... канд. мед. наук. М 2010.

10. Барсуков И.А. Ранние нарушения углеводного обмена: диагностика, скрининг, лечение: Автореф. дис. ... канд. мед. наук. М 2009.

11. Vamos E.P., Novak M., Kopp M., Musci I. The prevalence of diabetes in a large representative Hungarian population sample: 43nd Abstract. Annual Meeting of the EASD 2007; 162: 0377.

12. Дедов И.И., Чазова Т.Е., Сунцов Ю.И. Эпидемиология сахарного диабета. М: Медицина для Вас 2003;3-6, 36-37, 45-50.


Review

For citations:


Dreval' A.V., Trigolosova I.V., Vinogradova A.V., Ilovaĭskaia I.A. The prevalence of diabetes mellitus among the patients with acromegaly. Problems of Endocrinology. 2012;58(3):9-11. https://doi.org/10.14341/probl20125839-11

Views: 449


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)